Davis Polk advised an ad hoc group of senior secured noteholders in connection with the chapter 11 restructuring of FTS International, Inc. and certain of its subsidiaries (collectively, …
Davis Polk is advising Cboe Global Markets on its acquisition of BIDS Trading, a registered broker-dealer and the operator of the BIDS Alternative Trading System. The transaction is…
Davis Polk is advising an ad hoc group of noteholders (the “Ad Hoc Group”) in connection with a restructuring of Superior Energy Services, Inc. and its subsidiaries (collectively, the …
Davis Polk is advising an ad hoc group of holders of senior secured notes in connection with the chapter 11 restructuring of FTS International, Inc. and certain of its subsidiaries …
Davis Polk advised the dealer manager in connection with a “modified Dutch auction” cash tender offer by MicroStrategy Incorporated for 432,313 of its shares of common stock at a purchase…
Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion,…
Davis Polk is advising Brookfield Business Partners L.P. on its $13.2 billion acquisition of the Power Solutions business of Johnson Controls International plc. The transaction is expected…
Davis Polk is advising SUEZ S.A. on its $601 million sale of 20% of SUEZ Water Resources Inc. to PGGM. The transaction is expected to be completed by the first half of 2019, subject to…
Davis Polk is advising Williams on its $10.5 billion acquisition of all of the outstanding public common units of Williams Partners L.P. in an all stock-for-unit transaction at a 1.494…